Hosted on MSN11mon
Intranasal 5-MeO-DMT Clinical Trial Offers Hope For Treatment-Resistant Depression
See: Atai Invests $50M In Beckley Psytech For Short-Duration Psychedelics Development BPL-003 is a synthetic and patent-protected benzoate salt formulation of 5-MeO-DMT (aka mebufotenin) designed ...
A Psychedelic Molecule Controls Your Consciousness at the Moment of Death, New Theory Suggests
Some researchers believe DMT, a powerful psychedelic that may naturally occur in the brain, could be your soul’s “ferryman.” ...
Hosted on MSN11mon
Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta's Influence
Partners Beckley Psytech and atai Life Sciences (NASDAQ:ATAI) have jointly announced positive initial results from a Phase 2a study of Beckley’s novel formulation of 5-MeO-DMT in Treatment ...
Guggenheim starts GH Research at Buy, sees long-term upside potential
Guggenheim initiated coverage of GH Research (GHRS) with a Buy rating and $32 price target The firm’s thesis on GH is based around the belief that rapid-acting psychedelics like 5-MeO-DMT have the ...
CNN1y
GH Research Plc
or 5-MeO-DMT, therapies. The company was founded by Theis Terwey, Florian Schönharting, and Magnus Halle in 2018 and is headquartered in Dublin, Ireland.